Furthermore, frequencies of CD161+ cells in CD8+ T cells were significantly decreased in COVID-19 positive non-HD patients independent on severity of disease, which was not seen in COVID-19 positive HD patients (Figures 4I, J). This evidence concerns the gene KLRB1 and COVID-19.